Member Exclusive

Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment

Future Medicinal Chemistry Editorial by Daniel Merk (Goethe University Frankfurt, Germany) discussing the potential of retinoid X receptor gamma-targeting agents to repair or reverse multiple sclerosis damage to the CNS through boosting remyelination.

Go to the profile of RegMedNet
Aug 12, 2016

Please sign in or register for FREE

No comments yet.